Article Text

Download PDFPDF
Case report
Health insurance coverage for vulnerable children: two HIV orphans with Burkitt lymphoma and their quest for health insurance coverage in Kenya
  1. Sandra Langat1,
  2. Festus Njuguna1,
  3. Gertjan Kaspers2,3 and
  4. Saskia Mostert2,3
  1. 1Department of Pediatrics, Moi Teaching and Referral Hospital, Eldoret, Kenya
  2. 2Department of Pediatric Oncology-Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
  3. 3Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
  1. Correspondence to Dr Saskia Mostert; s.mostert{at}amsterdamumc.nl

Abstract

The United Nations and WHO have summoned governments from low-income and middle-income countries to institute universal health coverage and thereby improve their population’s healthcare access and outcomes. Until now, few countries responded favourably to this international plea. The HIV/AIDS epidemic, a major global public health challenge, resulted in over 11 million orphans in sub-Saharan Africa. Extended families have taken responsibility for more than 90% of these children. HIV orphans are likely to be poorer and less healthy. Burkitt lymphoma is the most common childhood cancer in sub-Saharan Africa. If orphans need lifesaving chemotherapy, appointing legal guardians becomes necessary to access health insurance. However, rules and regulations involved may be unclear and costly. This hinders its access for poor families who need it most. Uninsured children risk hospital detention over unpaid medical bills and have lower survival. Our case report depicts the quest for health insurance coverage of two HIV orphans with Burkitt lymphoma in Kenya.

  • global Health
  • HIV / AIDS
  • paediatric oncology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors SL: conceptualised and designed the data collection instrument, analysed and interpreted the data, drafted the initial manuscript and approved the final manuscript as submitted. FN: conceptualised and designed the study, analysed and interpreted the data, critically reviewed and revised the manuscript and approved the final manuscript as submitted. GK: conceptualised and designed the study, analysed and interpreted the data, critically reviewed and revised the manuscript and approved the final manuscript as submitted. SM: conceptualised and designed the study and data collection instrument, analysed and interpreted the data, critically reviewed and revised the manuscript and approved the final manuscript as submitted.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.